| Oct 19 |
Goldman Sachs: Merck & Co., Inc. (NYSE:MRK) Is A Stock With High Consensus ROE
|
| Oct 18 |
Merck & Co. (MRK): Strong Growth Driven by Keytruda and New Vaccine Approvals
|
| Oct 18 |
UBS upgrades view on U.S. stocks to attractive - here are its top picks
|
| Oct 18 |
Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
|
| Oct 18 |
MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win
|
| Oct 18 |
Merck antibody reduces RSV-related disease, hospitalizations in trial
|
| Oct 18 |
Merck RSV therapy cuts respiratory infections by 60% in infants
|
| Oct 18 |
Investors in Merck (NYSE:MRK) have seen respectable returns of 48% over the past three years
|
| Oct 18 |
Merck & Co., Inc. (MRK): Among the Blue Chip Stocks With Low PE Ratios
|
| Oct 17 |
Is Merck & Co., Inc. (MRK) the Most Promising Long-Term Stocks According to Hedge Funds?
|
